News & Press
Axoft raises $55M Series A for hydrogel neural probe commercialization after Nature publication
TechCrunch4/8/2026·04/08/26🌐 USA
Summary
Axoft closed a $45M Series A led by Andreessen Horowitz Bio immediately following publication of their ultra-soft hydrogel neural probe data in Nature, which showed 18-month stable recording with zero glial scarring in non-human primates. The round will fund regulatory filings and scale-up of their novel fabrication process.
Why it matters
The combination of landmark Nature publication and immediate large A-round is a textbook neurotech commercialization playbook. Axoft's 18-month NHP data with zero scarring is the strongest materials result yet for long-term BCI implants.
#BCI#Electrode Technology#Industry#Neural Interfaces#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in